RNA5SP384

Across TCGA pan-cancer cohorts, RNA5SP384 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNA5SP384 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNA5SP384 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP384 expression acts as an unfavorable survival marker, although some lineages such as ESCA and BLCA show a favorable association.

LUAD, MESO, and KIRC are the cancer types where RNA5SP384 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.109	0.750	<.001	108	view →
MESO	DFS	Tertile	II,III,IV	0.059	0.382	<.001	81	view →
KIRC	OS	Tertile	All	0.450	0.650	<.001	75	view →
UCEC	OS	Tertile	IV	0.066	0.755	<.001	48	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	45	view →
OV	OS	Tertile	IV	0.053	0.772	<.001	36	view →
PAAD	OS	Tertile	II,III,IV	0.217	0.561	<.001	27	view →
SKCM	OS	Tertile	III,IV	0.344	0.707	.008	24	view →
ACC	DFS	Tertile	All	0.089	0.666	.017	18	view →
ESCA	OS	Tertile	III,IV	0.800	0.371	.041	12	view →
SARC	OS	Tertile	All	0.233	0.601	.015	6	view →
BLCA	OS	Tertile	All	0.879	0.332	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNA5SP384–LUAD (OS)

Open the LUAD breakdown →